T38.5X2S Poisoning by other estrogens and progestogens, intentional self-harm, sequela

Name of the Condition

• Poisoning by other estrogens and progestogens, intentional self-harm, sequela

Summary

This condition represents the residual effects of intentional self-harm involving poisoning by estrogens or progestogens not classified elsewhere. It includes long-term consequences resulting from deliberate exposure to these hormonal agents, which may have occurred in therapeutic or non-therapeutic contexts.

Causes

The causes stem from intentional overdose or exposure to estrogens or progestogens, such as through deliberate ingestion of medications containing these substances. This may involve prescribed or non-prescribed formulations, including contraceptives, hormone replacement therapies, or other hormonal preparations. The sequela reflects lasting health impacts following the initial self-harm event.

Risk Factors

• History of intentional self-harm or suicidal behavior
• Access to hormonal agents (e.g., contraceptives, hormone therapies)
• Mental health conditions affecting judgment
• Polypharmacy involving hormonal agents
• Prior exposure to estrogens or progestogens

Symptoms

Symptoms vary based on the specific agent and dose but may include persistent nausea, vomiting, abdominal pain, dizziness, or changes in menstrual patterns. Severe cases could involve chronic thromboembolic events, hepatic dysfunction, or endocrine disturbances. Sequelae may manifest as ongoing organ damage or functional impairment.

Diagnosis

Diagnosis requires a thorough patient history, including medication use, exposure details, and intent. Clinical evaluation and laboratory tests assess residual effects. Documentation must link current symptoms to the prior self-harm event involving estrogens or progestogens.

Treatment Options

Treatment focuses on managing residual effects and preventing recurrence. This may include ongoing monitoring, supportive care, and addressing underlying mental health concerns. Interventions target specific sequelae, such as anticoagulation for thromboembolic events or endocrine management.

Prognosis and Follow-Up

Prognosis depends on the severity of initial poisoning and residual damage. Follow-up care is essential to monitor for complications and adjust treatment. Long-term management may involve regular assessments and coordination with mental health providers.

Complications

Complications can include chronic organ damage, persistent endocrine disturbances, or recurrent self-harm. Thromboembolic events, hepatic impairment, or irreversible hormonal imbalances may occur. Ongoing psychological support is critical to mitigate risks.

Lifestyle & Prevention

Lifestyle modifications may support recovery, such as adhering to prescribed treatments and avoiding further exposure to hormonal agents. Prevention strategies include secure storage of medications and access to mental health resources. Education on safe medication use is recommended.

When to Seek Professional Help

Seek immediate care for worsening symptoms, new onset of pain, or signs of recurrence. Ongoing support from healthcare providers is advised for persistent physical or psychological effects. Emergency services should be contacted for acute concerns.

Tips for Medical Coders

Document the sequela clearly, linking it to the prior intentional self-harm event. Specify the hormonal agents involved and confirm the residual effects. Ensure the code aligns with clinical documentation of long-term consequences. Note that this code is for sequelae; the acute event would use a different code.